247 related articles for article (PubMed ID: 15372846)
1. Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia.
Davidson MH; Ballantyne CM; Kerzner B; Melani L; Sager PT; Lipka L; Strony J; Suresh R; Veltri E;
Int J Clin Pract; 2004 Aug; 58(8):746-55. PubMed ID: 15372846
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial.
Goldberg AC; Sapre A; Liu J; Capece R; Mitchel YB;
Mayo Clin Proc; 2004 May; 79(5):620-9. PubMed ID: 15132403
[TBL] [Abstract][Full Text] [Related]
3. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of coadministration of ezetimibe and statins in elderly patients with primary hypercholesterolaemia.
Lipka L; Sager P; Strony J; Yang B; Suresh R; Veltri E;
Drugs Aging; 2004; 21(15):1025-32. PubMed ID: 15631531
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial.
Yu CC; Lai WT; Shih KC; Lin TH; Lu CH; Lai HJ; Hanson ME; Hwang JJ
BMC Res Notes; 2012 May; 5():251. PubMed ID: 22621316
[TBL] [Abstract][Full Text] [Related]
6. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
[TBL] [Abstract][Full Text] [Related]
7. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
Ballantyne CM; Houri J; Notarbartolo A; Melani L; Lipka LJ; Suresh R; Sun S; LeBeaut AP; Sager PT; Veltri EP;
Circulation; 2003 May; 107(19):2409-15. PubMed ID: 12719279
[TBL] [Abstract][Full Text] [Related]
8. Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
Simons L; Tonkon M; Masana L; Maccubbin D; Shah A; Lee M; Gumbiner B
Curr Med Res Opin; 2004 Sep; 20(9):1437-45. PubMed ID: 15383192
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia.
Gagné C; Bays HE; Weiss SR; Mata P; Quinto K; Melino M; Cho M; Musliner TA; Gumbiner B;
Am J Cardiol; 2002 Nov; 90(10):1084-91. PubMed ID: 12423708
[TBL] [Abstract][Full Text] [Related]
10. Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients.
Chow D; Chen H; Glesby MJ; Busti A; Souza S; Andersen J; Kohrs S; Wu J; Koletar SL
AIDS; 2009 Oct; 23(16):2133-41. PubMed ID: 19770624
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.
Gagné C; Gaudet D; Bruckert E;
Circulation; 2002 May; 105(21):2469-75. PubMed ID: 12034651
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On Study.
Bissonnette S; Habib R; Sampalis F; Boukas S; Sampalis JS;
Can J Cardiol; 2006 Oct; 22(12):1035-44. PubMed ID: 17036098
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
[TBL] [Abstract][Full Text] [Related]
15. Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia.
Assmann G; Kannenberg F; Ramey DR; Musliner TA; Gutkin SW; Veltri EP
Curr Med Res Opin; 2008 Jan; 24(1):249-59. PubMed ID: 18053317
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.
Kerzner B; Corbelli J; Sharp S; Lipka LJ; Melani L; LeBeaut A; Suresh R; Mukhopadhyay P; Veltri EP;
Am J Cardiol; 2003 Feb; 91(4):418-24. PubMed ID: 12586255
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and tolerability of ezetimibe coadministered with simvastatin in hypercholesterolemic patients: a randomized, 12-month double-blind extension study.
Strony J; Yang B; Hanson ME; Veltri EP
Curr Med Res Opin; 2008 Nov; 24(11):3149-57. PubMed ID: 18842166
[TBL] [Abstract][Full Text] [Related]
18. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
[TBL] [Abstract][Full Text] [Related]
19. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.
Davidson MH; McGarry T; Bettis R; Melani L; Lipka LJ; LeBeaut AP; Suresh R; Sun S; Veltri EP
J Am Coll Cardiol; 2002 Dec; 40(12):2125-34. PubMed ID: 12505224
[TBL] [Abstract][Full Text] [Related]
20. Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.
McCormack T; Harvey P; Gaunt R; Allgar V; Chipperfield R; Robinson P;
Int J Clin Pract; 2010 Jul; 64(8):1052-61. PubMed ID: 20487050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
